Patents by Inventor Ester Monlleó Mas

Ester Monlleó Mas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apaf-1 inhibitor compounds
    Patent number: 9040701
    Abstract: Derivatives of 2,5-piperazinedione of formula (I) are apoptotic peptidase activating factor 1 (Apaf-1) inhibitors, therefore they are useful as active pharmaceutical ingredients for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase of apoptosis.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: May 26, 2015
    Assignee: LABORATORIOS SALVAT, S.A.
    Inventors: Ángel Messeguer Peypoch, Alejandra Moure Fernández, Daniel González Pinacho, Isabel Masip Masip, Enrique Pérez Payá, Natividad García Villar, Ester Monlleó Mas, Juanlo Catena Ruiz
  • Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
    Patent number: 8822452
    Abstract: The compounds of formula (I) are derived from perhydroquinoline and perhydroisoquinoline and are useful as active pharmaceutical ingredients for the prophylaxis or treatment of diseases caused by 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1) enzyme-associated disorders, such as glaucoma, elevated ocular pressure, metabolic disorders, obesity, metabolic syndrome, dyslipidemia, hypertension, diabetes, atherosclerosis, Cushing's syndrome, psoriasis, rheumatoid arthritis, cognitive disorders, Alzheimer's disease or neurodegeneration.
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: September 2, 2014
    Assignee: Laboratorios Salvat, S.A.
    Inventors: Juan Lorenzo Catena Ruiz, Carme Serra Comas, Oscar Rey Puiggros, Albert Antolin Hernandez, Ester Monlleo Mas
  • APAF-1 INHIBITOR COMPOUNDS
    Publication number: 20120122868
    Abstract: Derivatives of 2,5-piperazinedione of formula (I) are apoptotic peptidase activating factor 1 (Apaf-1) inhibitors, therefore they are useful as active pharmaceutical ingredients for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase of apoptosis.
    Type: Application
    Filed: July 29, 2010
    Publication date: May 17, 2012
    Applicant: LABORATORIOS SALVAT, S.A.
    Inventors: Ángel Messeguer Pyepoch, Alejandra Moure Fernández, Daniel Gonzáles Pinacho, Isabel Masip Masip, Enrique Pérez Payá, Natividad García, Ester Monlleó Mas, Juanlo Catena Ruiz